drugset / Trial / NCT01015404
A Study to Assess the Safety of Using Fibroblast Growth Factor-2 With Periodontal Surgery in Japan (Phase 3)
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study aims to investigate the safety in using Trafermin (recombinant human basic fibroblast growth factor) with periodontal surgery.
Timeline
- Start
- 2009-11
- Primary completion
- 2010-03
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Trafermin | Protein / enzyme biologic | 0.2 ml | — |
| Subject | Trafermin | Protein / enzyme biologic | 0.3 % | — |
| Subject | Trafermin | Protein / enzyme biologic | 0.6 ml | — |